Shaowen Tang
Overview
Explore the profile of Shaowen Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
570
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cheng J, Zhu J, Chen R, Zhang M, Han B, Zhu M, et al.
Int J Clin Pharm
. 2025 Feb;
PMID: 39954223
Background: Anti-tuberculosis drug-induced liver injury (ATLI) is a significant adverse drug reaction with genetic susceptibility implications. Aim: This study aimed to integrate findings from systematic reviews and meta-analyses on genetic...
2.
Zhang X, Xu Z, Yao Y, Zheng H, Wu J, Hu J, et al.
Hypertension
. 2025 Jan;
82(3):532-541.
PMID: 39807594
Background: Although the information on the validation status of electronic sphygmomanometer (ES) devices in use in health care institutions and households is much more clinically relevant than that of ES...
3.
Xu X, Chen R, Lu L, Cheng J, He X, Pan H, et al.
Front Genet
. 2024 Nov;
15:1428319.
PMID: 39512799
Objective: The pathogenesis of antituberculosis drug-induced liver injury (AT-DILI) remains largely unknown. The current investigation aimed to determine the genetic contribution of the nuclear receptor subfamily 1 Group I member...
4.
Zhou Y, Jiang Y, Duan K, Li Q, Yang M, Lei Q, et al.
Inflammopharmacology
. 2024 Oct;
32(6):3799-3808.
PMID: 39397127
Background: Postoperative pain management is one of the most challenging treatments after orthopaedic surgery, and improved medical treatment options are urgently needed. This study aimed to evaluate the efficacy and...
5.
Han B, He Y, Zhu M, Zhang M, Lu L, Xu X, et al.
J Clin Pharmacol
. 2024 Sep;
65(2):197-205.
PMID: 39297668
The accumulation of protoporphyrin IX in the liver caused by isoniazid and rifampicin through the disorder of heme biosynthesis was considered an important mechanism of anti-tuberculosis drug-induced liver injury (ATLI)....
6.
Hao Z, Han B, Zhou X, Jian H, He X, Lu L, et al.
Pharmacogenomics
. 2024 Sep;
25(10-11):451-460.
PMID: 39263813
To investigate the association of DNA methylation, genetic polymorphisms and mRNA level of aminolevulinate synthase 1 (ALAS1) with antituberculosis drug-induced liver injury (AT-DILI) risk. Based on a 1:1 matched case-control...
7.
Lin X, Yong J, Gan M, Tang S, Du J
J Psychosom Obstet Gynaecol
. 2024 May;
45(1):2344079.
PMID: 38712869
Objective: To assess the impact of low-dose aspirin (LDA) on obstetrical outcomes through a meta-analysis of placebo-controlled randomized controlled trials (RCTs). Methods: A systematic search of the PubMed, Cochrane Library,...
8.
Li Q, Zhuang Z, Chen D, Tang S, Jiang Q
Orthop Surg
. 2024 Mar;
16(5):1019-1033.
PMID: 38506184
To compare the analgesic efficacy and adverse events of proximal versus distal ACB for adults undergoing knee arthroplasty, we searched PubMed, Cochrane, Web of Science, and Embase to identify all...
9.
Chen X, Pan H, Hao Z, Yi H, Tang S
J Clin Pharmacol
. 2024 Mar;
64(7):840-848.
PMID: 38436510
Antituberculosis drug-induced liver injury (ATLI) is a major adverse effect during antituberculosis treatment. Early detection or prediction is essential to prevent ATLI in antituberculosis treatment patients. The purpose of this...
10.
Zhu M, Chen X, Hao Z, He Y, Han B, Tang S
Pharmacogenomics
. 2023 Nov;
24(18):931-942.
PMID: 38019119
To evaluate the association between gene polymorphisms and susceptibility of antituberculosis drug-induced hepatotoxicity (ATDH). We searched the PubMed, Cochrane Library, Embase, Web of Science, Wan Fang and China National Knowledge...